Kidney cancer, Renal cell cancer, Secondary cancers
Results
Phase 2
This study looked at pazopanib for people with advanced kidney cancer (renal cancer) that hadn’t been treated yet.
This study was open to people whose cancer had spread to another part of the body and couldn’t have surgery to remove the cancer (advanced cancer).
This study was open for people to join between 2012 and 2016. These results were reported in 2018.
Cancer Research UK supported this study.
Recruitment start: 24 August 2012
Recruitment end: 31 August 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Emilio Porfiri
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Novartis
University of Birmingham
Last reviewed: 15 Oct 2020
CRUK internal database number: 6975
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
